Whitehawk Therapeutics Inc (WHWK)

$3.41 -0.02 (-0.58%)
Market Cap 161.89M
Revenue (ttm) 7.15M
Net Income (ttm) -20.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -288.11%
Debt to Equity Ratio 0.00
Volume 212,600
Avg Vol 165,050
Day's Range N/A - N/A
Shares Out 47.20M
Stochastic %K 40%
Beta 0.57
Analysts Sell
Price Target $5.67

Company Profile

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Industry: Biotechnology
Sector: Healthcare
Phone: 551-321-2234
Address:
2 Headquarters Plaza, East Building 11th Floor, Morristown, United States
swoooop
swoooop Apr. 6 at 8:02 PM
$WHWK this AACR setup is filthy; CEO exercised 775K+ options on Apr 1 and sold 26K shares the next day to cover taxes. That's it. Dude kept 793K shares going into the biggest catalyst of the year. If anything that's bullish af Here's why I'm loaded up. They have 3 ORAL presentations at AACR next week. Not posters. Orals. Companies don't get oral slots at AACR unless the data is real. The abstract committee reviews everything before accepting. I went back and looked at every phase readout with a conference presentation from 2022 to 2026. 90% positive outcome rate vs 77% baseline across 1,752 events. AACR ran 100% positive in that window. Crash rate gets cut in half for presenters too. Micro cap with triple oral presentations and the CEO loading the boat before the event. This is the kind of asymmetric setup I live for In size. NFA
0 · Reply
smartmoney43
smartmoney43 Mar. 13 at 12:49 AM
$WHWK
0 · Reply
STACKD0E
STACKD0E Mar. 9 at 1:49 PM
$ELDN $SNDX $WHWK $IMMX $XENE 🫡✨
0 · Reply
jnc1631
jnc1631 Mar. 6 at 11:04 PM
$WHWK a few more days like this and it’ll be near my average lol
0 · Reply
jnc1631
jnc1631 Mar. 6 at 6:05 PM
$WHWK alright what’s the news
0 · Reply
Jarvis7424
Jarvis7424 Mar. 5 at 7:33 PM
$WHWK can we break $3.5?
2 · Reply
War_Admiral
War_Admiral Mar. 3 at 9:04 PM
$WHWK good presentation this morning. I think the CEO is finding his groove. Three products or as Dave said 3 shots on goal makes this an interesting company.
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 3 at 6:19 PM
$WHWK Current Stock Price: $3.12 Contracts to trade: $2.5 WHWK Mar 20 2026 Call Entry: $0.59 Exit: $0.96 ROI: 64% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Aldobe115
Aldobe115 Feb. 27 at 7:24 PM
$WHWK
0 · Reply
Jarvis7424
Jarvis7424 Feb. 27 at 3:24 PM
$WHWK undervalued
0 · Reply
Latest News on WHWK
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

Mar 17, 2026, 4:30 PM EDT - 22 days ago

Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Mar 12, 2026, 8:00 AM EDT - 27 days ago

Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Feb 26, 2026, 8:00 AM EST - 5 weeks ago

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 18, 2026, 8:00 AM EST - 7 weeks ago

Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

Jan 8, 2026, 8:00 AM EST - 3 months ago

Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Dec 1, 2025, 8:00 AM EST - 4 months ago

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 26, 2025, 8:00 AM EST - 4 months ago

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Nov 11, 2025, 8:00 AM EST - 5 months ago

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Nov 6, 2025, 8:00 AM EST - 5 months ago

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

Oct 24, 2025, 12:30 PM EDT - 5 months ago

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

Oct 16, 2025, 8:30 AM EDT - 6 months ago

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

TEM

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Aug 7, 2025, 8:00 AM EDT - 8 months ago

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Jul 22, 2025, 8:00 AM EDT - 9 months ago

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

Jun 19, 2025, 8:00 AM EDT - 10 months ago

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 11 months ago

Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference

Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit

May 21, 2025, 8:00 AM EDT - 11 months ago

Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit

Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights

May 8, 2025, 4:05 PM EDT - 11 months ago

Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Mar 26, 2025, 8:00 AM EDT - 1 year ago

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

Mar 18, 2025, 4:00 PM EDT - 1 year ago

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

swoooop
swoooop Apr. 6 at 8:02 PM
$WHWK this AACR setup is filthy; CEO exercised 775K+ options on Apr 1 and sold 26K shares the next day to cover taxes. That's it. Dude kept 793K shares going into the biggest catalyst of the year. If anything that's bullish af Here's why I'm loaded up. They have 3 ORAL presentations at AACR next week. Not posters. Orals. Companies don't get oral slots at AACR unless the data is real. The abstract committee reviews everything before accepting. I went back and looked at every phase readout with a conference presentation from 2022 to 2026. 90% positive outcome rate vs 77% baseline across 1,752 events. AACR ran 100% positive in that window. Crash rate gets cut in half for presenters too. Micro cap with triple oral presentations and the CEO loading the boat before the event. This is the kind of asymmetric setup I live for In size. NFA
0 · Reply
smartmoney43
smartmoney43 Mar. 13 at 12:49 AM
$WHWK
0 · Reply
STACKD0E
STACKD0E Mar. 9 at 1:49 PM
$ELDN $SNDX $WHWK $IMMX $XENE 🫡✨
0 · Reply
jnc1631
jnc1631 Mar. 6 at 11:04 PM
$WHWK a few more days like this and it’ll be near my average lol
0 · Reply
jnc1631
jnc1631 Mar. 6 at 6:05 PM
$WHWK alright what’s the news
0 · Reply
Jarvis7424
Jarvis7424 Mar. 5 at 7:33 PM
$WHWK can we break $3.5?
2 · Reply
War_Admiral
War_Admiral Mar. 3 at 9:04 PM
$WHWK good presentation this morning. I think the CEO is finding his groove. Three products or as Dave said 3 shots on goal makes this an interesting company.
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 3 at 6:19 PM
$WHWK Current Stock Price: $3.12 Contracts to trade: $2.5 WHWK Mar 20 2026 Call Entry: $0.59 Exit: $0.96 ROI: 64% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Aldobe115
Aldobe115 Feb. 27 at 7:24 PM
$WHWK
0 · Reply
Jarvis7424
Jarvis7424 Feb. 27 at 3:24 PM
$WHWK undervalued
0 · Reply
jnc1631
jnc1631 Feb. 24 at 5:24 PM
$WHWK not sure why we are trending up but not complaining, is it due to beta?
0 · Reply
TapeHunter
TapeHunter Feb. 18 at 10:13 AM
$WHWK Event-driven equity where catalysts are infrequent.
0 · Reply
PortfolioRealm
PortfolioRealm Feb. 17 at 2:32 PM
$WHWK Obscure micro-cap; minimal public information.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 13 at 12:20 AM
$WHWK RSI: 67.03, MACD: 0.0679 Vol: 0.09, MA20: 2.80, MA50: 2.63 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Aldobe115
Aldobe115 Feb. 12 at 8:37 PM
$WHWK
0 · Reply
Aldobe115
Aldobe115 Feb. 12 at 8:37 PM
$WHWK
0 · Reply
Aldobe115
Aldobe115 Feb. 12 at 7:47 PM
$WHWK
0 · Reply
Jarvis7424
Jarvis7424 Feb. 12 at 6:17 PM
$WHWK break $3
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 20 at 9:24 AM
$WHWK Current Stock Price: $2.92 Contracts to trade: $2.5 WHWK Feb 20 2026 Call Entry: $0.97 Exit: $1.37 ROI: 41% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Jarvis7424
Jarvis7424 Jan. 16 at 6:05 PM
$WHWK slow crawl back to $5+
0 · Reply
JonCollins
JonCollins Jan. 14 at 8:30 PM
$WHWK showing reversal signs on low volume.
0 · Reply